Affinity Asset Advisors, LLC
- SEC CIK
- 0001773195
- 最新申報
- 2026/8/13
2021 年第 3 季持倉
持倉截至 2021/9/30，2021/11/12 申報。只含多頭部位，變化是跟 2021 年第 2 季比股數。
- 持股檔數
- 66
- 較 2021 年第 2 季 +4
- 總值
- $2.51 億
- 較 2021 年第 2 季 +$4,127 萬 (+19.7%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| BBIOBridgeBio Pharma, Inc. | COM | 654,435 | $3,067 萬 | 12.2% | +104,435+19.0% | 加碼 | 歷史 |
| VINCVincerx Pharma, Inc. | COM NEW | 1,005,000 | $1,625 萬 | 6.5% | +166,689+19.9% | 加碼 | 歷史 |
| MORFMorphic Holding, Inc. | COM | 270,755 | $1,534 萬 | 6.1% | +24,554+10.0% | 加碼 | 歷史 |
| NARIInari Medical, Inc. | Stock | 135,000 | $1,095 萬 | 4.4% | +50,000+58.8% | 加碼 | 歷史 |
| KURAKura Oncology, Inc. | COM | 530,000 | $992.7 萬 | 4.0% | +105,000+24.7% | 加碼 | 歷史 |
| SWTXSpringWorks Therapeutics, Inc. | COM | 126,013 | $799.4 萬 | 3.2% | +101,013+404.1% | 加碼 | 歷史 |
| CERECerevel Therapeutics Holdings, Inc. | COM | 259,966 | $766.9 萬 | 3.1% | +59,966+30.0% | 加碼 | 歷史 |
| OCULOcular Therapeutix, Inc | COM | 750,000 | $750.0 萬 | 3.0% | +500,000+200.0% | 加碼 | 歷史 |
| Retrophin Inc761299AB2 | NOTE 2.500% 9/1 | – | $705.6 萬 | 2.8% | – | – | – |
| ARYEARYA Sciences Acquisition Corp V | CLASS A ORD SHS | 702,500 | $694.1 萬 | 2.8% | +702,500 | 新進 | 歷史 |
| ACRSAclaris Therapeutics, Inc. | COM | 350,000 | $630.0 萬 | 2.5% | +75,000+27.3% | 加碼 | 歷史 |
| XLRNAcceleron Pharma Inc | COM | 35,350 | $608.4 萬 | 2.4% | −19,650−35.7% | 減碼 | 歷史 |
| ARYDARYA Sciences Acquisition Corp IV | CL A | 600,000 | $603.6 萬 | 2.4% | −100,000−14.3% | 減碼 | 歷史 |
| NAUTNautilus Biotechnology, Inc. | COM | 975,000 | $598.7 萬 | 2.4% | +75,000+8.3% | 加碼 | 歷史 |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 35,910 | $572.4 萬 | 2.3% | +15,910+79.6% | 加碼 | 歷史 |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 77,500 | $516.5 萬 | 2.1% | −64,918−45.6% | 減碼 | 歷史 |
| MRTXMirati Therapeutics, Inc. | COM | 27,500 | $486.5 萬 | 1.9% | +27,500 | 新進 | 歷史 |
| TVTXTravere Therapeutics, Inc. | COM | 200,000 | $485.0 萬 | 1.9% | +200,000 | 新進 | 歷史 |
| CRISCuris Inc | COM NEW | 575,000 | $450.2 萬 | 1.8% | −75,000−11.5% | 減碼 | 歷史 |
| CYTKCytokinetics Inc | COM NEW | 125,000 | $446.8 萬 | 1.8% | +55,000+78.6% | 加碼 | 歷史 |
| ESTAEstablishment Labs Holdings Inc. | COM | 60,000 | $429.5 萬 | 1.7% | +40,000+200.0% | 加碼 | 歷史 |
| IOVAIovance Biotherapeutics, Inc. | COM | 150,000 | $369.9 萬 | 1.5% | +50,000+50.0% | 加碼 | 歷史 |
| NSTGNS Wind Down Co., Inc. | COM | 75,000 | $360.1 萬 | 1.4% | +60,000+400.0% | 加碼 | 歷史 |
| Trillium Therapeutics Inc.89620X506 | COM NEW | 200,000 | $351.2 萬 | 1.4% | +200,000 | 新進 | – |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 203,183 | $339.3 萬 | 1.4% | +136,226+203.5% | 加碼 | 歷史 |
| Bellus Health Inc New07987C204 | COM NEW | 532,030 | $326.7 萬 | 1.3% | +232,030+77.3% | 加碼 | – |
| PRCTPROCEPT BioRobotics Corp | COM | 78,534 | $299.6 萬 | 1.2% | +78,534 | 新進 | 歷史 |
| Environmental Impact Acqu Co29408N106 | COM CL A | 300,000 | $296.7 萬 | 1.2% | +300,000 | 新進 | – |
| OBIOOrchestra BioMed Holdings, Inc. | ORD SHS | 300,000 | $296.7 萬 | 1.2% | 00.0% | 不變 | 歷史 |
| Medicus Sciences AcquisitionG5960S108 | CL A SHS | 300,000 | $292.5 萬 | 1.2% | 00.0% | 不變 | – |
| RCKTRocket Pharmaceuticals, Inc. | COM | 80,228 | $239.8 萬 | 1.0% | −39,772−33.1% | 減碼 | 歷史 |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 40,154 | $216.8 萬 | 0.9% | −9,846−19.7% | 減碼 | 歷史 |
| Bio Green Med Solution, Inc.23254L603 | COM | 400,000 | $210.8 萬 | 0.8% | +20,000+5.3% | 加碼 | – |
| Gossamer Bio, Inc.38341PAA0 | NOTE 5.000% 6/0 | – | $208.7 萬 | 0.8% | – | – | – |
| NTLAIntellia Therapeutics, Inc. | COM | 15,000 | $201.2 萬 | 0.8% | +5,000+50.0% | 加碼 | 歷史 |
| HARPHarpoon Therapeutics, Inc. | COM | 250,000 | $197.5 萬 | 0.8% | +200,000+400.0% | 加碼 | 歷史 |
| GBTGlobal Blood Therapeutics, Inc. | COM | 75,000 | $191.1 萬 | 0.8% | +55,000+275.0% | 加碼 | 歷史 |
| UTHRUnited Therapeutics Corp | COM | 10,000 | $184.6 萬 | 0.7% | +10,000 | 新進 | 歷史 |
| AFIBAcutus Medical, Inc. | COM | 200,000 | $176.8 萬 | 0.7% | +120,000+150.0% | 加碼 | 歷史 |
| ALDXAldeyra Therapeutics, Inc. | COM | 197,759 | $173.6 萬 | 0.7% | −2,241−1.1% | 減碼 | 歷史 |
| HZNPHorizon Therapeutics Public Ltd Co | SHS | 15,000 | $164.3 萬 | 0.7% | −10,000−40.0% | 減碼 | 歷史 |
| MREOMereo BioPharma Group plc | SPON ADS | 650,000 | $157.3 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| BFLYButterfly Network, Inc. | COM CL A | 150,000 | $156.6 萬 | 0.6% | +50,000+50.0% | 加碼 | 歷史 |
| SNCEScience 37 Holdings, Inc. | COM | 150,000 | $147.0 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| SDGRSchrodinger, Inc. | COM | 25,000 | $136.7 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| PCVXVaxcyte, Inc. | COM | 50,000 | $126.9 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| ZYMEZymeworks Inc. | COM | 38,814 | $112.7 萬 | 0.4% | +8,814+29.4% | 加碼 | 歷史 |
| CELLBruker Cellular Analysis, Inc. | COM | 55,000 | $107.6 萬 | 0.4% | +55,000 | 新進 | 歷史 |
| FOLDAmicus Therapeutics, Inc. | COM | 111,400 | $106.4 萬 | 0.4% | +111,400 | 新進 | 歷史 |
| LKFTLakefront Biotherapeutics NV | SPON ADR | 20,000 | $105.2 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| BHVNBiohaven Ltd. | COM | 7,500 | $104.2 萬 | 0.4% | +7,500 | 新進 | 歷史 |
| RCORRenovacor, Inc. | COM | 115,000 | $104.1 萬 | 0.4% | +115,000 | 新進 | 歷史 |
| KDNYChinook Therapeutics, Inc. | COM | 74,341 | $94.9 萬 | 0.4% | −125,659−62.8% | 減碼 | 歷史 |
| LUNGPulmonx Corp | COM | 25,000 | $90.0 萬 | 0.4% | −35,000−58.3% | 減碼 | 歷史 |
| Immatics N.V.N44445117 | *W EXP 07/01/202 | 190,000 | $80.0 萬 | 0.3% | 00.0% | 不變 | – |
| Achilles Therapeutics PLC00449L102 | SPONSORED ADS | 100,000 | $77.9 萬 | 0.3% | +20,000+25.0% | 加碼 | – |
| IPHAInnate Pharma SA | SPONSORED ADS | 125,000 | $77.1 萬 | 0.3% | +125,000 | 新進 | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 50,000 | $76.4 萬 | 0.3% | +50,000 | 新進 | 歷史 |
| TNGXTango Therapeutics, Inc. | COM | 50,000 | $64.7 萬 | 0.3% | +50,000 | 新進 | 歷史 |
| CTMXCytomX Therapeutics, Inc. | COM | 125,000 | $63.6 萬 | 0.3% | +50,000+66.7% | 加碼 | 歷史 |
| Beauty Health Co88331L116 | EQUITY WRT | 34,400 | $49.8 萬 | 0.2% | −10,600−23.6% | 減碼 | – |
| KROSKeros Therapeutics, Inc. | COM | 12,500 | $49.5 萬 | 0.2% | +12,500 | 新進 | 歷史 |
| Aslan Pharmaceuticals Ltd04522R101 | ADS | 250,000 | $44.5 萬 | 0.2% | +250,000 | 新進 | – |
| CRVSCorvus Pharmaceuticals, Inc. | COM | 50,000 | $24.2 萬 | 0.1% | +50,000 | 新進 | 歷史 |
| Renovacor, Inc.75989E114 | *W EXP 99/99/999 | 75,000 | $6.00 萬 | <0.1% | +75,000 | 新進 | – |
| Medicus Sciences AcquisitionG5960S124 | *W EXP 02/12/202 | 33,333 | $2.40 萬 | <0.1% | 00.0% | 不變 | – |
選擇權（7 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| State Street SPDR S&P Biotech ETF78464A870 | ETF | $8,800 萬 | – |
| SPYSPDR S&P 500 ETF Trust | ETF | $4,291 萬 | – |
| FLNAFilana Therapeutics, Inc. | COM | $465.6 萬 | – |
| EDITEditas Medicine, Inc. | COM | $410.8 萬 | – |
| RFLRafael Holdings, Inc. | COM CL B | $311.0 萬 | – |
| SEERSeer, Inc. | COM CL A | – | $172.7 萬 |
| IMVTImmunovant, Inc. | COM | – | $26.1 萬 |
2021 年第 2 季之後清倉（14 檔）
2021 年第 2 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2021 年第 2 季股數 | 2021 年第 2 季市值 | 2021 年第 2 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| PTGXProtagonist Therapeutics, Inc | COM | 140,100 | $628.8 萬 | 3.0% | 歷史 |
| MGNXMacrogenics Inc | COM | 80,000 | $214.9 萬 | 1.0% | 歷史 |
| EPIXESSA Pharma Inc. | COM NEW | 70,000 | $200.0 萬 | 1.0% | 歷史 |
| AXSMAxsome Therapeutics, Inc. | COM | 25,000 | $168.7 萬 | 0.8% | 歷史 |
| KALVKalVista Pharmaceuticals, Inc. | COM | 50,000 | $119.8 萬 | 0.6% | 歷史 |
| CGEMCullinan Therapeutics, Inc. | COM | 45,000 | $115.9 萬 | 0.6% | 歷史 |
| MRSNMersana Therapeutics, Inc. | COM | 85,000 | $115.4 萬 | 0.5% | 歷史 |
| BCTG Acquisition Corp05492W103 | COM | 100,000 | $113.8 萬 | 0.5% | – |
| Cerevel Therapeutics HLDNG I15678U102 | *W EXP 06/09/202 | 72,466 | $104.3 萬 | 0.5% | – |
| QSIQuantum-Si Inc | COM CL A | 75,000 | $92.0 萬 | 0.4% | 歷史 |
| Chardan Healthcr Acqstn 2 Co15957T206 | UNIT 99/99/9999 | 75,000 | $81.9 萬 | 0.4% | – |
| ITOSiTeos Therapeutics, Inc. | COM | 25,000 | $64.1 萬 | 0.3% | 歷史 |
| APLSApellis Pharmaceuticals, Inc. | COM | 10,000 | $63.2 萬 | 0.3% | 歷史 |
| CVRXCVRx, Inc. | COM | 7,500 | $21.0 萬 | 0.1% | 歷史 |